뒤로
OSE Immunotherapeutics SA(ORPOF) 가격
ORPOF 주가 차트
ORPOF 재무
OSE Immunotherapeutics SA
$11.6
0%
$0
종가: Jan 16, 16:00:00 GMT-5
$11.6
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
수입
자산 및 부채 명세서
현금 흐름
연간
분기별
ORPOF 소득
미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.
Follow-Up Questions
OSE Immunotherapeutics SA의 주요 재무제표는 무엇인가요?
ORPOF의 주요 재무 비율은 무엇인가요?
OSE Immunotherapeutics SA의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
OSE Immunotherapeutics SA은 수익성이 있나요?
OSE Immunotherapeutics SA에 부채가 있나요?
OSE Immunotherapeutics SA의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$11.6
시가
$11.6
일일 범위
$11.6 - $11.6
52주 범위
$11.6 - $11.6
거래량
748
평균 거래량
0
EPS(TTM)
--
배당수익률
--
시가총액
$260.5M
ORPOF란 무엇인가요?
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. The company is headquartered in Nantes, Pays De La Loire and currently employs 68 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.